Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Tumor Growth Factor-beta receptor family mediates diverse biological processes through highly conserved serine/threonine kinase activity triggered by specific growth factor ligands. Its paradoxical roles—as both tumor suppressors early on and promoters at later stages—make it both biologically fascinating and therapeutically challenging as an oncology target.
Inhibition of TGF-β receptor kinase activity or ligand/receptor binding, disrupting downstream signaling pathways.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tumor Growth Factor-beta Receptor (TGF-β Receptor).